The ever-growing price tag for new specialty drugs is testing the limits of the health care system to afford these revolutionary therapies.
Lauren Meyer, PharmD, MSPBA
Advertisement
Articles by Lauren Meyer, PharmD, MSPBA
New high-cost gene therapies are pushing health care providers to explore new methods to help the US health care system to fund specialty drugs.
Advertisement
Latest Updated Articles
That Drug Costs What?January 3rd 2019
Advertisement
Advertisement
Trending on Pharmacy Times
1
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
2
Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access
3
The Peptide Surge: Counseling Guidance on GLP-1s, Compounded Therapies, and What Patients Want to Know
4
Tec-Dara: Match Made in Heaven or Double Trouble?
5